Cite
HARVARD Citation
Gieffers, C. et al. (n.d.). Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma. European journal of cancer. pp. S200-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gieffers, C. et al. (n.d.). Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma. European journal of cancer. pp. S200-. [Online].